Recon: FDA places clinical hold on Neumora’s schizophrenia drug trial; WHO issues warning after falsified cough syrup ingredients seized in Pakistan
ReconJason Scott
BiotechnologyEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States